These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 26823707)
1. UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma. Yang H; Zhang C; Fang S; Ou R; Li W; Xu Y Int J Clin Exp Pathol; 2015; 8(11):13957-67. PubMed ID: 26823707 [TBL] [Abstract][Full Text] [Related]
2. Reduced Expression of Deubiquitinase USP33 Is Associated with Tumor Progression and Poor Prognosis of Gastric Adenocarcinoma. Chen Y; Pang X; Ji L; Sun Y; Ji Y Med Sci Monit; 2018 May; 24():3496-3505. PubMed ID: 29802710 [TBL] [Abstract][Full Text] [Related]
3. Potential prognostic marker ubiquitin carboxyl-terminal hydrolase-L1 does not predict patient survival in non-small cell lung carcinoma. Orr KS; Shi Z; Brown WM; O'Hagan KA; Lappin TR; Maxwell P; Percy MJ J Exp Clin Cancer Res; 2011 Aug; 30(1):79. PubMed ID: 21878121 [TBL] [Abstract][Full Text] [Related]
4. Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors. Zhang L; Qiu M; Jin Y; Ji J; Li B; Wang X; Yan S; Xu R; Yang D Int J Clin Exp Pathol; 2015; 8(9):11084-91. PubMed ID: 26617827 [TBL] [Abstract][Full Text] [Related]
5. Nedd4-1 is an exceptional prognostic biomarker for gastric cardia adenocarcinoma and functionally associated with metastasis. Sun A; Yu G; Dou X; Yan X; Yang W; Lin Q Mol Cancer; 2014 Nov; 13():248. PubMed ID: 25395181 [TBL] [Abstract][Full Text] [Related]
6. An abnormally high expression of ISL-1 represents a potential prognostic factor in gastric cancer. Guo C; Wang W; Shi Q; Chen P; Zhou C Hum Pathol; 2015 Sep; 46(9):1282-9. PubMed ID: 26142548 [TBL] [Abstract][Full Text] [Related]
7. TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling. Liu F; Cao QH; Lu DJ; Luo B; Lu XF; Luo RC; Wang XG Oncotarget; 2015 May; 6(13):11585-99. PubMed ID: 25839162 [TBL] [Abstract][Full Text] [Related]
8. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients. Hu X; Huang Z; Liao Z; He C; Fang X Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751 [TBL] [Abstract][Full Text] [Related]
9. Increased RhoA Activity Predicts Worse Overall Survival in Patients Undergoing Surgical Resection for Lauren Diffuse-Type Gastric Adenocarcinoma. Chang KK; Cho SJ; Yoon C; Lee JH; Park DJ; Yoon SS Ann Surg Oncol; 2016 Dec; 23(13):4238-4246. PubMed ID: 27364501 [TBL] [Abstract][Full Text] [Related]
10. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer. Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748 [TBL] [Abstract][Full Text] [Related]
11. Programmed death-ligand 1 expression in gastric adenocarcinoma is a poor prognostic factor in a high CD8+ tumor infiltrating lymphocytes group. Chang H; Jung WY; Kang Y; Lee H; Kim A; Kim HK; Shin BK; Kim BH Oncotarget; 2016 Dec; 7(49):80426-80434. PubMed ID: 27741514 [TBL] [Abstract][Full Text] [Related]
12. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer. Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108 [TBL] [Abstract][Full Text] [Related]
13. DIMT1 overexpression correlates with progression and prognosis in gastric carcinoma. Liu G; Peng X; Cai Y; Cheng A; Zha L; Wang Z Hum Pathol; 2017 Dec; 70():35-42. PubMed ID: 28601661 [TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients. Schröder C; Milde-Langosch K; Gebauer F; Schmid K; Mueller V; Wirtz RM; Meyer-Schwesinger C; Schlüter H; Sauter G; Schumacher U J Cancer Res Clin Oncol; 2013 Oct; 139(10):1745-55. PubMed ID: 23996067 [TBL] [Abstract][Full Text] [Related]
15. TRIM15 Exerts Anti-Tumor Effects Through Suppressing Cancer Cell Invasion in Gastric Adenocarcinoma. Chen W; Lu C; Hong J Med Sci Monit; 2018 Nov; 24():8033-8041. PubMed ID: 30412518 [TBL] [Abstract][Full Text] [Related]
16. Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer. Yang H; Liu Z; Yuan C; Zhao Y; Wang L; Hu J; Xie D; Wang L; Chen D Int J Clin Exp Pathol; 2015; 8(9):11092-9. PubMed ID: 26617828 [TBL] [Abstract][Full Text] [Related]
17. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer. Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771 [TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of deubiquitylating enzyme USP9X predicts poor prognosis in gastric cancer. Fu X; Xie W; Song X; Wu K; Xiao L; Liu Y; Zhang L Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):687-692. PubMed ID: 28274596 [TBL] [Abstract][Full Text] [Related]
19. Decreased expression of BRCA1-associated protein 1 predicts unfavorable survival in gastric adenocarcinoma. Yan S; He F; Luo R; Wu H; Huang M; Huang C; Li Y; Zhou Z Tumour Biol; 2016 May; 37(5):6125-33. PubMed ID: 26611647 [TBL] [Abstract][Full Text] [Related]
20. Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma. Wang J; Shen H; Fu G; Zhao D; Wang W Oncotarget; 2017 Feb; 8(6):9442-9450. PubMed ID: 28038462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]